News
Fintel on MSN19h
Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT)Fintel reports that on May 28, 2025, Leerink Partners downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback